Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

March 4, 2024 2024 Power 50

2024 Power 50: 28. Vlad Coric

PHOTO | CONTRIBUTED Dr. Vlad Coric, CEO and chairman of Biohaven.

Under Vlad Coric’s leadership, Biohaven Pharmaceuticals’ blockbuster migraine drug Nurtec ODT became a top-prescribed migraine medicine in its class in the United States.

The New Haven-based company launched Nurtec ODT, its first commercial product, in 2020, after winning U.S. Food and Drug Administration approval.

Biohaven attracted big names for marketing the drug, from reality TV celebrity Khloé Kardashian, to Beverly Hills 90210 star Tori Spelling and actor Whoopi Goldberg.

The drug’s popularity drew the eyes of Big Pharma, and in October 2022, Pfizer Inc. acquired Biohaven for $11.6 billion in cash, a deal that Coric said would expand distribution of the company’s migraine drugs.

But Coric didn’t just take his newfound riches and go home. Instead, after the Pfizer deal was complete, he launched a newly independent clinical-stage company in New Haven called Biohaven Ltd., which has been working on a pipeline of experimental medicines for a range of neurological disorders.

Find out who else is in the 2024 Power 50.

Coric has been well-received by Wall Street. He’s made appearances on well-known CNBC personality Jim Cramer’s “Mad Money” show.

Coric has decades of drug discovery and clinical development experience, including at the Yale School of Medicine and Bristol-Myers Squibb.

He earned his medical degree from the Wake Forest University School of Medicine and a bachelor’s degree in neurobiology and physiology at the University of Connecticut.

Find out who else is in the 2024 Power 50.

Sign up for Enews


Order a PDF